Michael J. James
Rheumatology Unit
Royal Adelaide Hospital
Adelaide
Australia
Name/email consistency: high
- Applying a research ethics committee approach to a medical practice controversy: the case of the selective COX-2 inhibitor rofecoxib. James, M.J., Cleland, L.G. J. Med. Ethics (2004)
- Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids. James, M.J., Ursin, V.M., Cleland, L.G. Am. J. Clin. Nutr. (2003)
- Eicosanoid production by human monocytes: does COX-2 contribute to a self-limiting inflammatory response?. James, M.J., Penglis, P.S., Caughey, G.E., Demasi, M., Cleland, L.G. Inflamm. Res. (2001)